소아기에 발병하는 염증성장질환(IBD)은 성인 IBD와 다른 질환인가? - 조기발병 소아 IBD의 역학적, 임상적, 유전학적 특성 및 치료 시 고려 사항-

키워드

참고문헌 (105)

1. Seo JK, "Inflammatory bowel disease in children: clinical, endoscopic, radiologic and histopathologic investigation", J Korean Med Sci, 7, pp.221~235 (1992)
2. 서현아, "소아 크론병에서 영양 치료의 효과", Pediatric Gastroenterology, Hepatology & Nutrition, 9(2), pp.210~217 (2006), 대한소아소화기영양학회
3. 이나영, "소아 크론병의 임상적 특징과 경과", Clinical Endoscopy, 34(4), pp.193~199 (2007), 대한소화기내시경학회
4. 이지현, "Infliximab: 불응성 크론병 치료법으로서의 유용성과 Top-down 관해 유도 요법으로서의 가능성", Pediatric Gastroenterology, Hepatology & Nutrition, 11(1), pp.28~35 (2008), 대한소아소화기영양학회
5. Abramson O, "Ncidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006", J Pediatr, 157, pp.233~239 (2010)
6. Turunen P, "Incidence of inflammatory bowel disease in Finnish children, 1987-2003", Inflamm Bowel Dis, 12, pp.677~683 (2006)
7. Ruyssers NE, "Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice", Inflamm Bowel Dis, 15, pp.491~500 (2009)
8. Thompson N, "Is measles vaccination a risk factor for inflammatory bowel disease", Lancet, 345, pp.1071~1074 (1995)
9. Hafner S, "The role of domestic hygiene in inflammatory bowel diseases: hepatitis A and worm infestations", Eur J Gastroenterol Hepatol, 20, pp.561~566 (2008)
10. Summers R, "Trichuris suis therapy in Crohn’s disease", Gut, 54, pp.87~ (2005)
11. Andersson RE, "Appendectomy and protection against ulcerative colitis", N Engl J Med, 344, pp.808~814 (2001)
12. Andersson RE, "Appendectomy is followed by increased risk of Crohn's disease", Gastroenterology, 124, pp.40~46 (2003)
13. Jowett S, "Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study", Gut, 53, pp.1479~1484 (2004)
14. Mahid SS, "Smoking and inflammatory bowel disease: a meta- analysis", Mayo Clin Proc, 81, pp.1462~1471 (2006)
15. McGilligan VE, "Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis", Inflam Bowel Dis, 13, pp.108~115 (2007)
16. Rubin DT, "Smoking and inflammatory bowel disease", Eur J Gastroenterol Hepatol, 12, pp.855~862 (2000)
17. Gasche C, "A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology", Inflamm Bowel Dis, 6, pp.8~15 (2000)
18. Silverberg MS, "oward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology", Can J Gastroenterol, 19, pp.5~36 (2005)
19. Levine A, "Pediatric modification of the montreal classification for inflammatory bowel disease: the paris classification", Inflamm Bowel Dis (2010)
20. Levine A, "Pediatric onset Crohn's colitis is characterized by genotype dependent age related susceptibility", Inflamm Bowel Dis, 13, pp.1509~1115 (2007)
21. Meinzer U, "Ileal involvement is age dependent in pediatric Crohn's disease", Inflamm Bowel Dis, 11, pp.639~644 (2005)
22. Markowitz J, "Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology", Inflamm Bowel Dis, 15, pp.714~719 (2009)
23. Ruemmele FM, "Characteristics of inflammatory bowel disease with onset during the first year of life", J Pediatr Gastroenterol Nutr, 43, pp.603~609 (2006)
24. Glocker EO, "Inflammatory bowel disease and mutation affecting the interleukin-10 receptor", N Engl J Med, 361, pp.2033~2045 (2009)
25. Van Limbergen J, "Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease", Gastroenterology, 135, pp.1114~1122 (2008)
26. Vernier-Massouille G, "Natural history of pediatric Crohn's disease: a population-based cohort study", Gastroenterology, 135, pp.1106~1113 (2008)
27. Heyman MB, "Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry", J Pediatr, 146, pp.35~40 (2005)
28. Kappelman MD, "The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States", Clin Gastroenterol Hepatol, 5, pp.1424~1429 (2007)
29. Kugathasan S, "Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study", J Pediatr, 143, pp.525~531 (2003)
30. Sawczenko A, "Prospective survey of childhood inflammatory bowel disease in the British isles", Lancet, 357, pp.1093~1094 (2001)
31. Newby EA, "Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases", J Pediatr Gastroenterol Nutr, 46, pp.539~ (2008)
32. Sagiv-Friedgut K, "Early-onset Crohn disease is associated with male sex and a polymorphism in the IL-6 promoter", J Pediatr Gastroenterol Nutr, 50, pp.22~26 (2010)
33. Sauer CG, "Pediatric inflammatory bowel disease: Highlighting pediatric differences in IBD", Med Clin North Am, 94, pp.35~52 (2010)
34. Henriksen M, "Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study)", Inflamm Bowel Dis, 12, pp.543~550 (2006)
35. Hyams J, "The natural history of corticosteroid therapy for ulcerative colitis in children", Clin Gastroenterol Hepatol, 4, pp.1118~1123 (2006)
36. Gupta N, "Presentation and disease course in early- compared to later-onset pediatric Crohn's disease", Am J Gastroenterol, 103, pp.2092~2098 (2008)
37. Keljo DJ, "Course and treatment of perianal disease in children newly diagnosed with Crohn's disease", Inflamm Bowel Dis, 15, pp.383~387 (2009)
38. Karban A, "Risk factors for perianal Crohn's disease: the role of genotype, phenotype, and ethnicity", Am J Gastroenterol, 102, pp.1702~1708 (2007)
39. Romano C, "Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children", Pediatrics, 122, pp.1278~1281 (2008)
40. Martland GT, "Indeterminate colitis: definition, diagnosis, implications and a plea for nosological sanity", Histopathology, 50, pp.83~96 (2007)
41. Wells AD, "Natural history of indeterminate colitis", Br J Surg, 78, pp.179~181 (1991)
42. Moum B, "Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists", Digestion, 56, pp.377~381 (1995)
43. Farmer RG, "Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients", Dig Dis Sci, 38, pp.1137~1146 (1993)
44. Silverberg MS, "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology", Can J Gastroenterol, 19, pp.5~36 (2005)
45. Cucchiara S, "The microbiota in inflammatory bowel disease in different age groups", Dig Dis, 27, pp.252~258 (2009)
46. Frank DN, "Gastrointestinal microbiology enters the metagenomics era", Curr Opin Gastroenterol, 24, pp.4~10 (2008)
47. Taurog JD, "The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats", J Exp Med, 180, pp.2359~2364 (1994)
48. Fabia R, "Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat", Digestion, 54, pp.248~255 (1993)
49. Swidsinski A, "Mucosal flora in inflammatory bowel disease", Gastroenterology, 122, pp.44~54 (2002)
50. Sartor RB, "Review article: role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis", Aliment Pharmacol Ther, 11(3), pp.17~22 (1997)
51. Seksik P, "Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon", Gut, 52, pp.237~242 (2003)
52. Mylonaki M, "Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool", Eur J Gastroenterol Hepatol, 16, pp.775~778 (2004)
53. Meyer AM, "The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease", J Clin Gastroenterol, 38, pp.772~775 (2004)
54. Swidsinski A, "Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora", Inflamm Bowel Dis, 14, pp.147~161 (2008)
55. Conte MP, "Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease", Gut, 55, pp.1760~1767 (2006)
56. Schippa S, "Dominant genotypes in mucosa associated Escherichia coli strains from pediatric patients with inflammatory bowel disease", Inflamm Bowel Dis, 15, pp.661~672 (2009)
57. Kirsner JB, "Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis", Ann Intern Med, 59, pp.133~ (1963)
58. Yang H, "Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews", Gut, 34, pp.517~524 (1993)
59. Halme L, "Family and twin studies in inflammatory bowel disease", World J Gastroenterol, 12, pp.3668~3672 (2006)
60. Orholm M, "Concordance of inflammatory bowel disease among Danish twins: results of a nationwide study", Scand J Gastroenterol, 35, pp.1075~1081 (2000)
61. Abreu MT, "Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease", Gastroenterology, 123, pp.679~688 (2002)
62. Chamaillard M, "Advances and perspectives in the genetics of inflammatory bowel diseases", Clin Gastroenterol Hepatol, 4, pp.143~151 (2006)
63. Kobayashi KS, "Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract", Science, 307, pp.731~734 (2005)
64. Fiocchi C, "Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand", Dig Dis, 27, pp.226~235 (2009)
65. Biank V, "Pediatric inflammatory bowel disease: clinical and molecular genetics", Inflamm Bowel Dis, 13, pp.1430~1438 (2007)
66. Hampe J, "A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1", Nat Genet, 39, pp.207~211 (2006)
67. Rioux JD, "Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis", Nat Genet, 39, pp.596~604 (2007)
68. Parkes M, "Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility", Nat Genet, 39, pp.830~832 (2007)
69. Kugathasan S, "Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease", Nat Genet, 40, pp.1211~1215 (2008)
70. Duerr RH, "A genome-wide association study identifies IL23R as an inflammatory bowel disease gene", Science, 314, pp.1461~ (2006)
71. Wellcome Trust Case Control Consortium, "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls", Nature, 447, pp.661~673 (2007)
72. Barrett JC, "Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease", Nat Genet, 40, pp.955~962 (2008)
73. ranke A, "Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis", Nat Genet, 40, pp.713~715 (2008)
74. Anderson CA, "Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship", Gastroenterology, 136, pp.523~529 (2009)
75. Franke A, "Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility", Nat Genet, 40, pp.1319~1323 (2008)
76. Barrett JC, "Genome-wide association defines more than 30 distinct susceptibility loci for Crohn disease", Nat Genet, 40, pp.955~962 (2008)
77. McGovern DPB, "Genome-wide association identifies multiple ulcerative colitis susceptibility loci", Nat Genet, 42, pp.332~337 (2010)
78. Latella G, "News from the "5th international meeting on inflammatory bowel disease" CAPRI 2010", J Crohn Colitis, 4, pp.690~702 (2010)
79. Peterson N, "Genetic variants in the autophagy pathway contribute to paediatric Crohn’s disease", Gut, 57, pp.1336~1337 (2008)
80. Essers JB, "Established genetic risk factors do not distinguish early and later onset Crohn's disease", Inflamm Bowel Dis, 15, pp.1508~1514 (2009)
81. Scherr R, "Genetic determinants of pediatric inflammatory bowel disease: is age of onset genetically determined", Dig Dis, 27, pp.236~239 (2009)
82. Ridder L, "Genetic susceptibility has a more important role in pediatric onset Crohn disease than in adult-onset Crohn disease", Inflamm Bowel Dis, 13, pp.1083~1092 (2007)
83. Imielinski M, "Common variants at five new loci associated with early-onset inflammatory bowel disease", Nat Genet, 41, pp.1335~1340 (2009)
84. Henderson P, "Genetics of childhood-onset inflammatory bowel disease", Inflamm Bowel Dis, 17, pp.346~361 (2011)
85. Sagiv-Friedgut K, "Early-onset Crohn disease is associated with male sex and a polymorphism in the IL-6 promoter", J Pediatr Gastroenterol Nutr, 50, pp.22~26 (2010)
86. Akobeng AK, "Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease", Cochrane Database Syst Rev, (1), pp.3715~ (2005)
87. Sutherland L, "Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis", Cochrane Database Syst Rev, (3), pp.543~ (2003)
88. Turner D, "Consensus for managing acute severe ulcerative colitis in children: A systemic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN", Am J Gastroenterol, 11 (2011)
89. Alfadhli AA, "Methotrexate for induction of remission in refractory Crohn's disease", Cochrane Database Syst Rev, (1), pp.3459~ (2005)
90. Uhlen S, "Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study", Inflamm Bowel Dis, 12, pp.1053~1057 (2006)
91. Turner D, "Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease", Am J Gastroenterol, 102, pp.2804~2812 (2007)
92. Hyams J, "Induction and maintenance infliximab therapy for the treatment of moderate- to-severe Crohn's disease in children", Gastroenterology, 132, pp.863~873 (2007)
93. Hyams JS, "Long term outcome of maintenance infliximab therapy in children with Crohn's disease", Inflamm Bowel Dis, 15, pp.816~822 (2009)
94. D'Haens G, "Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial", Lancet, 371, pp.660~667 (2008)
95. Hyams JS, "Risk", benefit Strategies must be employed pediatric Crohn’s disease, 2009, pp.27, 291~296
96. Thayu M, "Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease", J Pediatr Gastroenterol Nutr, 40, pp.220~222 (2005)
97. Drini M, "Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease", Med J Aust, 189, pp.464~465 (2008)
98. Sandborn W, "SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn’s disease naive to immunomodulators and biologic therapy", Am J Gastroenterol, 103(1), pp.436~ (2008)
99. Lichtenstein G, "Infliximab administered as 3-dose induction followed by scheduled maintenance therapy in IBD: comparable clinical outcomes with or without concomitant immunomodulators", Gastroenterology, 132(2), pp.146~ (2007)
100. Van Assche G, "Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial", Gastroenterology, 134, pp.1861~1868 (2008)
101. Hyams JS, "Development and validation of a pediatric Crohn's disease activity index", J Pediatr Gastroenterol Nutr, 12, pp.439~447 (1991)
102. Turner D, "Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study", Gastroenterology, 133, pp.423~432 (2007)
103. Griffiths AM, "Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently", Dig Dis, 27, pp.404~411 (2009)
104. Walters TD, "Mechanisms of growth impairment in pediatric Crohn's disease", Nat Rev Gastroenterol Hepatol, 6, pp.513~523 (2009)
105. De Benedetti F, "Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis", Endocrinology, 142, pp.4818~4826 (2001)

관련 논문AI추천